Erratum to: Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group

[1]  P Reichardt,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  S. Bonvalot,et al.  Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group , 2016, Annals of surgery.

[3]  Narasimhan P. Agaram,et al.  Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma , 2016, Annals of surgery.

[4]  P. Sugarbaker,et al.  Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results , 2016, Annals of Surgical Oncology.

[5]  A. Hayes-Jordan.  Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy in DSRCT: Progress and Pitfalls , 2015, Current Oncology Reports.

[6]  Seung-Yong Jeong,et al.  Prognostic factors for reoperation of recurrent retroperitoneal sarcoma: The role of clinicopathological factors other than histologic grade , 2015, Journal of surgical oncology.

[7]  L. Mariani,et al.  Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma: Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection , 2015, Annals of Surgical Oncology.

[8]  P. Casali,et al.  Correlation between radiological assessment and histopathological diagnosis in retroperitoneal tumors: analysis of 291 consecutive patients at a tertiary reference sarcoma center. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  A. D. Dei Tos,et al.  High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma , 2014, Clinical Sarcoma Research.

[10]  U. Mansmann,et al.  Effectiveness of Regional Hyperthermia With Chemotherapy for High-Risk Retroperitoneal and Abdominal Soft-Tissue Sarcoma After Complete Surgical Resection: A Subgroup Analysis of a Randomized Phase-III Multicenter Study , 2014, Annals of surgery.

[11]  M. Bischof,et al.  Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis , 2014, BMC Cancer.

[12]  P. Casali,et al.  Emerging therapies for adult soft tissue sarcoma , 2014, Expert review of anticancer therapy.

[13]  A. Miah,et al.  Optimal management of primary retroperitoneal sarcoma: an update , 2014, Expert review of anticancer therapy.

[14]  A. Lazar,et al.  Locoregional Disease Patterns in Well-Differentiated and Dedifferentiated Retroperitoneal Liposarcoma: Implications for the Extent of Resection? , 2014, Annals of Surgical Oncology.

[15]  P. Bruzzi,et al.  Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group. , 2014, European journal of cancer.

[16]  J. Blay,et al.  Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  M. Brennan,et al.  Management of recurrent retroperitoneal sarcoma , 2014, Journal of surgical oncology.

[18]  C. Catton,et al.  Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Robin L. Jones,et al.  Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma , 2013, Sarcoma.

[20]  P. Choong,et al.  Retroperitoneal sarcomas: A review of disease spectrum, radiological features, characterisation and management , 2013, Journal of medical imaging and radiation oncology.

[21]  J. Blay,et al.  Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region , 2013, International Journal of Clinical Oncology.

[22]  H. Neuman,et al.  The Role of Radiation in Retroperitoneal Sarcomas , 2013, Current Treatment Options in Oncology.

[23]  Luigi Mariani,et al.  Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  R. Pollock,et al.  Quality of Local Treatment or Biology of the Tumor: Which are the Trump Cards for Loco-regional Control of Retroperitoneal Sarcoma? , 2013, Annals of Surgical Oncology.

[25]  P. Terrier,et al.  Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma? , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  M. Bertagnolli,et al.  Locoregional Recurrence After Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Adverse Impact of Multifocal Disease and Potential Implications of Dose Escalation , 2013, Annals of Surgical Oncology.

[27]  A. Niccoli-Asabella,et al.  A retrospective study comparing contrast-enhanced computed tomography with 18F-FDG-PET/CT in the early follow-up of patients with retroperitoneal sarcomas , 2013, Nuclear medicine communications.

[28]  J. Ludwig,et al.  Complete Cytoreduction and HIPEC Improves Survival in Desmoplastic Small Round Cell Tumor , 2013, Annals of Surgical Oncology.

[29]  J. Verweij,et al.  Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. , 2012, The Lancet. Oncology.

[30]  M. Heslin,et al.  Soft Tissue Sarcoma, Version 1.2021 Featured Updates to the NCCN Guidelines , 2022 .

[31]  C. Raut,et al.  Technical Considerations in Surgery for Retroperitoneal Sarcomas: Position Paper from E-Surge, a Master Class in Sarcoma Surgery, and EORTC–STBSG , 2012, Annals of Surgical Oncology.

[32]  L. Mariani,et al.  Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  G. Powell,et al.  Value of PET scan in patients with retroperitoneal sarcoma treated with preoperative radiotherapy. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[34]  S. Hochwald,et al.  Multimodality local therapy for retroperitoneal sarcoma. , 2010, International journal of radiation oncology, biology, physics.

[35]  S. Martinez,et al.  Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis. , 2011, The Journal of surgical research.

[36]  R. Pollock,et al.  Surgery in Retroperitoneal Soft Tissue Sarcoma: A Call for a Consensus Between Europe and North America , 2011, Annals of Surgical Oncology.

[37]  D. Manas,et al.  Surgery for retroperitoneal soft tissue sarcomas: aggressive re-resection of recurrent disease is possible. , 2011, Annals of the Royal College of Surgeons of England.

[38]  M. Fiore,et al.  Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy? , 2010, Annals of Surgical Oncology.

[39]  M. Heslin,et al.  Recurrent retroperitoneal sarcoma: impact of biology and therapy on outcomes. , 2010, Journal of the American College of Surgeons.

[40]  C. Fisher,et al.  Surgical management of primary retroperitoneal sarcoma , 2010, The British journal of surgery.

[41]  L. Mariani,et al.  Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control , 2010, Annals of Surgical Oncology.

[42]  Y. Yoruk,et al.  Recurrent solitary fibrous tumor of the pleura: significant response to radiotherapy , 2010, Medical oncology.

[43]  D. Sahani,et al.  Proton-Beam, Intensity-Modulated, and/or Intraoperative Electron Radiation Therapy Combined with Aggressive Anterior Surgical Resection for Retroperitoneal Sarcomas , 2010, Annals of Surgical Oncology.

[44]  K. Hunt,et al.  Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[45]  L. Qin,et al.  Predicting Outcome by Growth Rate of Locally Recurrent Retroperitoneal Liposarcoma: The One Centimeter Per Month Rule , 2009, Annals of surgery.

[46]  R. Benjamin,et al.  Computed tomography scan‐driven selection of treatment for retroperitoneal liposarcoma histologic subtypes , 2009, Cancer.

[47]  R. Pollock,et al.  Multifocality in Retroperitoneal Sarcoma: A Prognostic Factor Critical to Surgical Decision-Making , 2009, Annals of surgery.

[48]  J. Blay,et al.  Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  C. Mussi,et al.  Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  L. Qin,et al.  A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients , 2008, Clinical Cancer Research.

[51]  L. Qin,et al.  Why Do Patients with Low-Grade Soft Tissue Sarcoma Die? , 2008, Annals of Surgical Oncology.

[52]  F. Farrokhyar,et al.  A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma , 2008, Cancer.

[53]  V. Sondak,et al.  Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma. , 2007, International journal of radiation oncology, biology, physics.

[54]  L. Koniaris,et al.  Should Soft Tissue Sarcomas Be Treated at High-volume Centers?: An Analysis of 4205 Patients , 2007, Annals of surgery.

[55]  M. Heslin,et al.  Soft tissue sarcoma: preoperative and postoperative imaging for staging. , 2007, Surgical oncology clinics of North America.

[56]  F. van Coevorden,et al.  Long-term prognosis of primary retroperitoneal soft tissue sarcoma. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[57]  K. Hunt,et al.  Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. , 2007, International journal of radiation oncology, biology, physics.

[58]  M. Kattan,et al.  Subtype Specific Prognostic Nomogram for Patients With Primary Liposarcoma of the Retroperitoneum, Extremity, or Trunk , 2006, Annals of surgery.

[59]  T. Pawlik,et al.  Long-Term Results of Two Prospective Trials of Preoperative External Beam Radiotherapy for Localized Intermediate- or High-Grade Retroperitoneal Soft Tissue Sarcoma , 2006, Annals of Surgical Oncology.

[60]  P. Rutkowski,et al.  Surgery Combined With Intraoperative Brachytherapy in the Treatment of Retroperitoneal Sarcomas , 2006, Annals of Surgical Oncology.

[61]  J. Blay,et al.  Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[62]  J. Thomas,et al.  Surgical management of primary and recurrent retroperitoneal liposarcoma , 2005, The British journal of surgery.

[63]  F. Brunicardi,et al.  Schwartz's Principles of Surgery , 2004 .

[64]  L. Mariani,et al.  Retroperitoneal soft tissue sarcomas , 2004, Cancer.

[65]  S. Mocellin,et al.  Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis , 2004, Cancer.

[66]  J. Donohue,et al.  Operative Management of Primary Retroperitoneal Sarcomas: A Reappraisal of an Institutional Experience , 2004, Annals of surgery.

[67]  K. Hunt,et al.  Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  Samuel Singer,et al.  Histologic Subtype and Margin of Resection Predict Pattern of Recurrence and Survival for Retroperitoneal Liposarcoma , 2003, Annals of surgery.

[69]  B. Bui,et al.  Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[70]  B. O'Sullivan,et al.  Retroperitoneal sarcomas: combined modality treatment approaches , 2002, Current opinion in oncology.

[71]  F. van Coevorden,et al.  Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[72]  P. Terrier,et al.  Prognostic factors in retroperitoneal sarcoma , 2001, Cancer.

[73]  C. Dykewicz.  Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  D. Rattner,et al.  Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. , 2001, International journal of radiation oncology, biology, physics.

[75]  L. Anderson,et al.  High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. , 2000, International journal of radiation oncology, biology, physics.

[76]  J M Woodruff,et al.  Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. , 1998, Annals of surgery.

[77]  J M Woodruff,et al.  Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.